Ghoneim, Sara
Butt, Muhammad Umer
Hamid, Osama
Shah, Aun
Asaad, Imad
2020-09-22T14:25:48Z
2020-09-22T14:25:48Z
2020-09-09
2589-9368
https://www.sciencedirect.com/science/article/pii/S2589936820300372?via%3Dihub#!
http://hdl.handle.net/20.500.12010/13547
26 páginas
application/pdf
eng
Metabolism Open
reponame:Expeditio Repositorio Institucional UJTL
instname:Universidad de Bogotá Jorge Tadeo Lozano
non-alcoholic steatohepatitis
metabolic syndrome
African American
obesity
diabetes mellitus
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study
Artículo
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/acceptedVersion
Acceso restringido
https://doi.org/10.1016/j.metop.2020.100057
Background
The novel coronavirus disease (COVID-19) emerged from China in 2019 and rapidly spread worldwide. Patients with metabolic comorbid conditions are more susceptible to infection by COVID-19. Metabolic syndrome is a constellation of interlinked metabolic risk factors that predispose patients to increased risk of complications. Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and non-alcoholic steatohepatitis (NASH) is the aggressive form of NAFLD.
http://purl.org/coar/resource_type/c_6501